Observational studyBMJ open gastroenterology2025
Physician adenoma detection rates and risk of post-colonoscopy colorectal cancer in a sequential screening programme: a retrospective cohort study.
Observational study in BMJ open gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLong-term colorectal cancer (CRC) monitoring is common in Asia, but assessing colonoscopy effectiveness through adenoma detection rates (ADRs) remains uncommon. This study aimed to identify potential associations between ADR and risk of post-colonoscopy CRC (PCCRC).
methodsThis retrospective, longitudinal, observational study included participants (aged 40-74 years) with initial positive results and subsequent colonoscopy recruited from a community-based, multicentre, CRC screening programme from January 2012 to December 2022 in Tianjin, China. ADR was defined as the proportion of colonoscopies in which at least one adenoma was detected at the provider level. The primary outcome was PCCRC, defined as any CRC diagnosed 6 months after initial colonoscopy. ADR groups were categorised according to quartile distribution (<42%, 42%-55%, 55%-64% and >64%) or dichotomised as at or above vs below the median for statistical analyses. PCCRC incidence rates were expressed as the number of events per 1000 person-years.
resultsAmong 9957 included participants, 116 PCCRC cases were detected in 33 881 person-years of follow-up. PCCRC incidence rates per 1000 person-years were 4.34, 3.76, 2.62 and 2.69 from the lowest to the highest ADR group, respectively. ADR was significantly inversely associated with PCCRC risk. Participants in the highest ADR group had 49% lower risk of PCCRC than those in the low ADR group (adjusted HR 0.51, 95% CI 0.29 to 0.88). Multivariate-adjusted restricted cubic spline analyses identified a linear dose-response relationship between ADR and PCCRC risk.
conclusionsThis study illustrates the relationship between endoscopist competence, as measured by ADR, and CRC risk after colonoscopy, which can guide assessment of monitoring programmes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.